Insomnia Treatment Market

Global Market Study on Insomnia Treatment: High Demand for OTC Sleep Aids & OTC Sleep Supplements to Persist

Insomnia Treatment Market Segmented By OTC drugs and Prescription Drugs in Hospital Pharmacies, Retail Pharmacies, E-commerce and Drug Stores, hypermarkets

  • June-2018
  • PMRREP23203
  • 163 Pages
  • Healthcare


Increase in the cases of insomnia, including the ones that go undiagnosed, is a severe public health concern. While effective and affordable treatment options are available in the global market, approximately 25% of adult population already suffer from sleeping disorders, of which around 6-10% have been diagnosed with insomnia.

With increased prevalence of insomnia, a growing number of patients is seeking pharmacological treatment. Presently, numerous options are available in the insomnia treatment market; however, research continues to be on the bandwagon, to seek newer pharmacological treatments.

As suggested by a recent conducted research study by Persistence Market Research, the global insomnia treatment market is projected to register a promising CAGR of 5.2% in terms of value during the forecast period 2018-2026. By the end of 2026, the market will possibly reach over a value worth US$ 7.5 billion.

Find Out More about the Report Coverage


  • Sunovion Pharmaceuticals, Inc.
  • Natrol, LLC
  • GlaxoSmithKline Plc.
  • Sanofi SA
  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH
  • Mallinckrodt
  • PERNIX Therapeutics
  • Takeda Pharmaceutical Company Limited
  • Merck & Co. Inc.
  • Others.

Increasing consumption of OTC drugs & new innovations to fuel the market growth

insomnia treatment market

Millions of people are suffering from sleep-related disorders, and a majority of them have been preferring the OTC sleep medicines. According to United Nations, population in the age group of 60 years and above is projected to grow by 56% by 2030, which indicates that there is a growing geriatric population.

Majorly, this factor will increase the demand for OTC insomnia therapeutic, since this population base is more susceptible to sleep deprivation. Commonly, OTC sleep aid such as natrol melatonin and unisom sleep gel that has minimum side effects dominate the global insomnia treatment market. OTC drugs are expected to represent the maximum share of the market revenue through 2026.

As the need for improved treatment is increasing, leading pharmaceutical companies are focusing more on conducting vigorous research to find newer treatments. Several unique pharmacological categories, including neurokinin1 receptor antagonist, 5-HT1A agonist, 5-HT6 antagonist, H3 agonists, corticotropin-releasing hormone antagonists, cytokines, glutamatergic antagonists, and adenosine enhancers, are being investigated in order to introduce improved treatments to the market, in near future.

To treat chronic insomnia, cognitive behavioral therapy for insomnia (CBT-I) is also found to be a highly effective therapy, especially for older adults. Some other therapies used for the treatment of insomnia include Stimulus control therapy (SCT), Sleep-restriction therapy (SRT), Relaxation therapy, and Sleep hygiene and education (SHE).

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Developing economies to present attractive markets; sizeable patient pool with undiagnosed insomnia to pave the way for opportunities

Developing countries such as China and India are expected to witness a growth in demand for healthcare facilities and sleep aids over the next few years. This would eventually create a series of opportunities for leading manufacturers, planning to expand in these regional markets and attain higher market shares.

An expanding undiagnosed insomnia patient pool suggests that there is a clinically significant level of insomnia among global population, which prompts at the critical need for improved recognition, diagnosis, and treatment.

According to the research, billions are being spent on sound sleep. The booming multi-billion dollar sleep-health economy is an answer to the increasing number of insomnia cases, eventually opening an array of beneficial market opportunities for both private and consumer-oriented pharmaceutical companies, manufacturers, retailers, and health service providers.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Media Release


Generic Oncology Drugs Market

Sales revenue from generic oncology drugs in 2020 was US$ 23 Bn, which is expected to surge to US$ 41.5 Bn by the end of 2031. .

Emergency Contraceptive Pills Market

Global Emergency contraceptive pills market to reach US$ 1,230 million, and is expected to exhibit sluggish growth and reflect less than 3% CAGR during 2017-2022.

Active Pharmaceutical Ingredient Market

Global active pharmaceutical ingredient market is predicted to expand at a CAGR of more than 4% over the forecast period (2021–2031)..

Microbiome Therapeutic Market

Global human microbiome market is estimated to attain US$ 1.8 Bn by 2026 ending, up from US$ 360 Mn in 2020, growing at a CAGR of 20% during forecast period of 2021-26.

Our Clients

Our Clients